Purchase Order 36C25925P0185
Award Date
11/20/24
Potential Completion Date
11/30/24
Potential Value
$18K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Galderma Laboratories, L.P.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dallas, TX 75201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NEMOLIZUMAB-ILTO 30MG INJ,PEN to the U.S. Department of Veterans Affairs (VA), specifically to Veterans Integrated Service Network (VISN) 6. The contract, valued at $3,078.60, was awarded to Galderma Laboratories, L.P., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract is a firm fixed-price delivery order placed under the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule...
This federal contract award, valued at $18,760.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $34,490.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 8, 2024. The award is for the delivery of TREMFYA 100 MG/ML INJECTOR/ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key...
This federal contract award, valued at $26,903.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, with a period of performance ending on March 10, 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC,...
This federal contract award, valued at $2,175.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, with a completion date of December 12, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,787.60, is a delivery order for the supply of "NEMLUVIO 30 MG PENS" medical products. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $41,956.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the delivery of TREMFYA 100 MG/ML SYRINGEML, a medical product, to support military healthcare...
This federal contract award is for the delivery of OPZELURA 1.5% cream in 60 gram quantities to the Defense Logistics Agency (DLA), a defense agency. The $5,339.51 fixed-price contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen Drug Corp is a significant supplier of pharmaceuticals and medical supplies to...
This federal contract award, valued at $8,250.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of the drug product TREMFYA 100 MG/ML INJECTORML, with a delivery completion date of May 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract, valued at $8,250.45, was awarded by the Medical Supply Chain division of the U.S. Department of Defense on June 24, 2024, with a completion date of June 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds several indefinite delivery contracts...